| Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study (NCT03911739) | T. John Winhusen, PhD | 2021-06-14 |
| Actigraphy and Neonatal Abstinence Syndrome of Hospitalized Newborn in Intensive Care Units (NCT04983563) | University Hospital, Caen | 2021-03-01 |
| A Trial to Determine Weight Gain Benefits of Caloric Supplementation for NAS Infants (NCT04419857) | Yale University | 2020-12-04 |
| Averting NAS Among Opioid-Using Young Women Receiving MAT Using Buprenorphine (NCT04611659) | Meharry Medical College | 2020-11-01 |
| Clinical Trial to Decrease Length of Stay in Infants With Neonatal Abstinence Syndrome With an Exclusive Human Milk Diet (NCT04508348) | The University of Texas Health Science Center at San Antonio | 2020-08-31 |
| Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study (NCT03911466) | T. John Winhusen, PhD | 2020-07-21 |
| Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome (NCT04298853) | Indiana University | 2020-06-30 |
| tAN to Mitigate Withdrawal Behaviors in Neonates (NCT04588519) | Spark Biomedical, Inc. | 2020-05-30 |
| MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome (NCT05937594) | Milton S. Hershey Medical Center | 2020-01-15 |
| Assessing the Effects of Auricular Acupressure on Newborns With NAS (NCT03890562) | Virginia Commonwealth University | 2019-09-04 |
| Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions (NCT04049799) | University of Vermont | 2019-08-08 |
| Interventions to Help Infants Recover in the Hospital (NCT03881553) | Elisabeth Salisbury, PhD | 2019-07-19 |
| Sound Processing Changes in Babies With Opioid Exposure (NCT03567603) | University of Rochester | 2019-03-25 |
| Actigraphy and Neonatal Abstinence Syndrome (NCT03977545) | University Hospital, Caen | 2019-01-23 |
| The Effect of Music Therapy on Newborns (NCT03987165) | Tulane University | 2018-12-10 |
| MOM NEST Study: Maternal Opioid Medication: Naltrexone Efficacy Study (NCT03718104) | Boston Medical Center | 2018-12-01 |
| Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure (NCT03608696) | Thomas Jefferson University | 2018-08-29 |
| Clonidine as Adjunct to Morphine for Neonatal Abstinence Syndrome (NCT03762317) | Hennepin County Medical Center, Minneapolis | 2018-04-30 |
| Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy (NCT03092011) | The Cooper Health System | 2018-02-21 |
| Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young Brain (NCT03396588) | Henrietta Bada | 2017-12-07 |
| Weighted Blankets With Infants With NAS (NCT03113656) | TriHealth Inc. | 2017-07-14 |
| Quantitative Assessment of Sucking for Early Diagnosis of Brain Injury in Infants at High Risk (NCT03246243) | Boston Children's Hospital | 2017-03-29 |
| Efficacy and Outcomes of a Non-Pharmacological Intervention for Neonatal Abstinence Syndrome (NCT02801331) | Elisabeth B Salisbury | 2017-03-09 |
| Buprenorphine Dose Adjustments and Gestational Age (NCT03028883) | St. Louis University | 2016-12-02 |
| Morphine Versus Methadone for Opiate Exposed Infants With Neonatal Abstinence Syndrome (NCT02851303) | University of New Mexico | 2016-10-01 |
| Efficacy of Auricular Acupuncture on Neonatal Abstinence Syndrome (NCT02872077) | University of South Florida | 2016-08-01 |
| Conflict Between Maternal Autonomy and Child Health in Substance-use (NCT02797990) | London School of Hygiene and Tropical Medicine | 2016-05-01 |
| The Effect of Aromatherapy on Neonatal Abstinence Syndrome and Salivary Cortisol Levels (NCT03097484) | John M. Daniel | 2015-07-25 |
| Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent Women (NCT01965704) | Stanford University | 2014-09-09 |
| Role of Low Lactose Infant Formula In The Management of Neonatal Abstinence Syndrome (NCT03549936) | MetroHealth Medical Center | 2014-07-09 |
| Donor Human Milk in Neonatal Abstinence Syndrome (NCT02182973) | Neolac Inc dba Medolac Laboratories | 2014-06-01 |
| Acupuncture in Neonatal Abstinence Syndrome (NAS) Babies (NCT02062151) | University of South Florida | 2014-02-01 |
| Improving Outcomes in Neonatal Abstinence Syndrome (NCT01958476) | Tufts Medical Center | 2013-09-01 |
| RESPECT-PLUS: Services for Infants With Prenatal Opiate Exposure (NCT02334111) | Boston Medical Center | 2013-07-01 |
| Utility of Psychosocial Intervention in Improving Outcome for Methadone-exposed Infants and Their Mothers (NCT01889121) | Dr. Henry Akinbi | 2013-02-01 |
| Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS) (NCT01708707) | Pediatrix | 2012-12-01 |
| The Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome (NCT01754324) | Children's Hospital Medical Center, Cincinnati | 2012-12-01 |
| Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepines (NCT01671410) | Thomas Jefferson University | 2012-08-01 |
| Interest of Concentrations in Meconium of Buprenorphine and Methadone as a Prognostic Factor of NAS Outcome (NCT03334981) | University Hospital, Caen | 2012-07-01 |
| Fetal and Infant Effects of Maternal Buprenorphine Treatment (NCT01561079) | Johns Hopkins University | 2012-02-01 |
| Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome (NCT01452789) | Thomas Jefferson University | 2011-11-01 |
| NAS Treatment - Opiate Versus Non-Opiate (NCT01734551) | Henrietta Bada | 2011-09-01 |
| Clonidine to Treat Iatrogenic-induced Opioid Dependence in Infants (NCT01360450) | Johns Hopkins University | 2011-07-01 |
| Physiology and Therapeutic Management of Neonatal Abstinence Syndrome (NCT02768844) | University of Massachusetts, Worcester | 2011-04-01 |
| Comparison Between Methadone and Morphine for Neonatal Opiate Withdrawal (NCT01804075) | Eastern Maine Medical Center | 2011-01-01 |
| Clonidine for Neonatal Abstinence Syndrome Study (NCT01175668) | Baystate Medical Center | 2010-07-01 |
| RCT of High- vs. Standard-Calorie Formula for Methadone-Exposed Infants (NCT02178189) | University of Pittsburgh | 2010-04-01 |
| Treatment of Neonatal Abstinence Syndrome (NCT01723722) | Eastern Maine Medical Center | 2007-01-01 |
| Vagal Tone and Neonatal Abstinence Syndrome (NCT00496951) | Johns Hopkins University | 2006-09-01 |
| Buprenorphine for the Treatment of Neonatal Abstinence Syndrome (NCT00521248) | Thomas Jefferson University | 2004-04-01 |
| Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome (NCT00510016) | National Institute on Drug Abuse (NIDA) | 2002-07-01 |
| How to Treat Opiate Withdrawal in Neonates (NCT02810782) | University of Zurich | 2001-06-01 |